Wedbush has assumed coverage of Voyager Therapeutics (VYGR) with an outperform rating, highlighting the company’s TRACER ...

Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Gerber has grown skeptical of Musk's other ventures in recent years, and has said previously that his side projects are ...

Wedbush has an outperform rating on Apple's stock heading into the holiday season and a 12-month price target of $300, that's about 28% above its current price. It's the highest price target among the ...

Wedbush would characterize demand for iPhone 16 so far since its September launch as “slightly ahead to generally in line with expectations ...

News of an investigation by the Federal Trade Commission into Microsoft (NASDAQ:MSFT) is "not a worry" with Chairwoman Lina ...

For some, Black Friday kicks off the holiday shopping season, a period of time that Apple (NASDAQ:AAPL) is heavily dependent ...

We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Jared Cohen, Goldman Sachs president of global affairs, co-head of the Goldman Sachs Global Institute, said while talking to ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

IMAX Corp.'s shares have climbed 71.2% in 2024, and analyst firm Wedbush sees more upside ahead for the high-end ...